No photo of Max Meyrath

Max Meyrath

MSc, Mister, Doctor, PhD

    • rue Henri Koch, 29

      4354 Esch-Sur-Alzette

      Luxembourg

    • 629
      Citations
    20142024

    Research activity per year

    Filter
    Patent

    Search results

    • 2022

      Conolidine analogues as selective ACKR3 modulators for the treatment of cancer and cardiovascular diseases

      Chevigne, A. (Inventor), Szpakowska, M. (Inventor), Namjoshi, O. A. (Inventor), Blough, B. E. (Inventor), Decker, A. M. (Inventor) & Meyrath, M. (Inventor), 30 Jun 2022, IPC No. A61K31/397; A61K31/4025; A61K31/404; A61K31/407; A61K31/439; A61K31/4439; A61K31/454; A61K31/496; A61K31/499; A61K31/551; A61P13/12; A61P17/02; A61P25/28; A61P29/00; A61P3/04; A61P31/12; A61P31/18; A61P35/00; A61P37/08; A61P9/00; A61P9/10; C07D401/06; C07D403/06; C07D403/12; C07D471/18; C07D487/04;, Patent No. WO2022136486A1, 22 Dec 2021, Priority date 22 Dec 2020, Priority No. EP20216606A

      Research output: Patent

    • 2020

      Novel selective ACKR3 modulators and uses thereof

      Chevigne, A. (Inventor), Meyrath, M. (Inventor) & Szpakowska, M. (Inventor), 12 Nov 2020, IPC No. A61K38/00; A61K47/62; A61K47/64; A61K48/00; C07K7/08; C12N15/86; G01N33/58, Patent No. WO 2020/225070A1, 30 Apr 2020, Priority date 3 May 2019, Priority No. EP19172560A

      Research output: Patent

      Open Access
    Your message has successfully been sent.
    Your message was not sent due to an error.